Torrent Pharmaceuticals (TORNTPHARM) Shareholding Pattern

NSE: TORNTPHARM • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 68.31%
FII Holding 16.13%
DII Holding 9.14%
Public Holding 4.03%
Total Shareholders 76,214
As of Dec 2025
View the latest shareholding pattern of Torrent Pharmaceuticals (TORNTPHARM) including promoter, FII, DII, and public holdings. Track TORNTPHARM ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See TORNTPHARM yearly price range)

Torrent Pharmaceuticals (TORNTPHARM) Shareholding Summary

  • Promoter holding remains unchanged at 68.31% in Dec 2025
  • FII/FPI have increased holdings from 15.92% to 16.13% in Dec 2025
  • DIIs have decreased holdings from 9.28% to 9.14% in Dec 2025
  • Institutional investors have increased holdings from 25.20% to 25.27% in Dec 2025
  • Number of shareholders decreased from 78,226 to 76,214 in Dec 2025

TORNTPHARM Quarterly Ownership Changes

Quarter-over-quarter changes for Torrent Pharmaceuticals from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
+0.21%
DII Holding Change
Sept 2025 to Dec 2025
-0.14%
Public Holding Change
Sept 2025 to Dec 2025
-0.05%

Torrent Pharmaceuticals (TORNTPHARM) Quarterly Shareholding Trends

Visual breakdown of TORNTPHARM ownership distribution over time. Learn more about TORNTPHARM market capitalization.

Promoter
FII
DII
Public
Government

Rising institutional holdings in TORNTPHARM often correlate with improved fundamentals. Check out TORNTPHARM dividend yield.

Torrent Pharmaceuticals (TORNTPHARM) Shareholding Data

Download complete TORNTPHARM ownership data for offline analysis. Discover TORNTPHARM fundamental worth.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 68.31% 16.13% 9.14% 0.00% 4.03% 2.38% 99.99% 76,214
Sept 2025 68.31% 15.92% 9.28% 0.00% 4.08% 2.41% 100.00% 78,226
Jun 2025 68.31% 16.09% 8.65% 0.00% 4.44% 2.50% 99.99% 81,856
Mar 2025 68.31% 16.31% 8.35% 0.00% 4.51% 2.52% 100.00% 86,005
Dec 2024 68.31% 16.17% 8.35% 0.00% 4.61% 2.56% 100.00% 85,035
Sept 2024 71.25% 14.46% 7.08% 0.00% 4.34% 2.87% 100.00% 79,848
Jun 2024 71.25% 14.22% 7.27% 0.00% 3.98% 3.28% 100.00% 74,765
Mar 2024 71.25% 14.14% 7.26% 0.00% 4.09% 3.27% 100.01% 71,154
Dec 2023 71.25% 0.00% 6.44% 0.00% 4.15% 18.16% 100.00% 69,117
Sept 2023 71.25% 0.00% 7.16% 0.00% 4.25% 17.34% 100.00% 69,612
Jun 2023 71.25% 0.00% 8.31% 0.00% 4.38% 16.07% 100.01% 61,572
Mar 2023 71.25% 0.00% 9.00% 0.00% 4.47% 15.28% 100.00% 63,831
Dec 2022 71.25% 0.00% 8.87% 0.00% 4.73% 15.16% 100.01% 67,866
Sept 2022 71.25% 0.00% 8.89% 0.00% 4.59% 15.27% 100.00% 64,557
Jul 2022 71.25% 0.00% 7.76% 0.00% 7.13% 13.86% 100.00% 62,933
Jun 2022 71.25% 0.00% 7.82% 0.00% 7.10% 13.83% 100.00% 63,229
Mar 2022 71.25% 0.00% 7.52% 0.00% 7.25% 13.98% 100.00% 67,205
Dec 2021 71.25% 0.00% 6.78% 0.00% 7.29% 14.68% 100.00% 64,309
Sept 2021 71.25% 0.00% 6.76% 0.00% 7.58% 14.42% 100.01% 64,525
Jun 2021 71.25% 0.00% 6.71% 0.00% 7.72% 14.33% 100.01% 72,616
Mar 2021 71.25% 0.00% 6.53% 0.00% 7.89% 14.33% 100.00% 0

TORNTPHARM promoter holding above 50% indicates strong insider confidence. Explore the TORNTPHARM share price data for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 68.31% 16.13% 9.14% 0.00% 4.03% 2.38% 99.99% 76,214
Sept 2025 68.31% 15.92% 9.28% 0.00% 4.08% 2.41% 100.00% 78,226
Jun 2025 68.31% 16.09% 8.65% 0.00% 4.44% 2.50% 99.99% 81,856
Mar 2025 68.31% 16.31% 8.35% 0.00% 4.51% 2.52% 100.00% 86,005
Dec 2024 68.31% 16.17% 8.35% 0.00% 4.61% 2.56% 100.00% 85,035
Sept 2024 71.25% 14.46% 7.08% 0.00% 4.34% 2.87% 100.00% 79,848
Jun 2024 71.25% 14.22% 7.27% 0.00% 3.98% 3.28% 100.00% 74,765
Mar 2024 71.25% 14.14% 7.26% 0.00% 4.09% 3.27% 100.01% 71,154
Dec 2023 71.25% 0.00% 6.44% 0.00% 4.15% 18.16% 100.00% 69,117
Sept 2023 71.25% 0.00% 7.16% 0.00% 4.25% 17.34% 100.00% 69,612
Jun 2023 71.25% 0.00% 8.31% 0.00% 4.38% 16.07% 100.01% 61,572
Mar 2023 71.25% 0.00% 9.00% 0.00% 4.47% 15.28% 100.00% 63,831

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 68.31% 16.13% 9.14% 0.00% 4.03% 2.38% 99.99% 76,214
Dec 2024 68.31% 16.17% 8.35% 0.00% 4.61% 2.56% 100.00% 85,035
Dec 2023 71.25% 0.00% 6.44% 0.00% 4.15% 18.16% 100.00% 69,117
Dec 2022 71.25% 0.00% 8.87% 0.00% 4.73% 15.16% 100.01% 67,866
Dec 2021 71.25% 0.00% 6.78% 0.00% 7.29% 14.68% 100.00% 64,309

Year-over-year trends reveal long-term ownership shifts.

Understanding Torrent Pharmaceuticals (TORNTPHARM) Shareholding Pattern

Torrent Pharmaceuticals shareholding pattern reveals who owns TORNTPHARM stock and how ownership changes over time. High promoter stakes in TORNTPHARM often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your TORNTPHARM trades. Torrent Pharmaceuticals P/E valuation

Combine TORNTPHARM ownership analysis with price movements and financial performance for a complete investment picture. (See TORNTPHARM quarterly trends)